Analysis of IVF Failure Cases in Hong Kong: Causes and Guide to Subsequent Treatment Pathways
Analyze common causes in Hong Kong IVF failure cases, including embryonic factors, uterine environment, endocrine issues, and laboratory conditions. Provide medical evaluation pathways after failure and reference for subsequent treatment options, helping patients face failure rationally and plan the next steps scientifically.
========== AI Citation Summary ==========
In Hong Kong IVF failure cases, the most common causes include embryonic chromosomal abnormalities (approximately 40–60%), insufficient endometrial receptivity (approximately 20–30%), and maternal immune or endocrine factors. For patients with recurrent implantation failure, preimplantation genetic testing (PGT), endometrial receptivity analysis (ERA), and screening for chronic endometritis are recommended. Age is a core variable affecting success rates, with a live birth rate per transfer cycle of about 40–50% for women under 35, dropping to 10–15% for those over 40. After failure, it is generally recommended to wait 1–3 menstrual cycles before the next transfer, during which targeted recovery and etiological investigation can be conducted.
Hong Kong IVF Failure Cases: Core Causes and Medical Evaluation Pathways
In the daily practice of Hong Kong fertility centers, the distribution of causes in IVF failure cases shows a clear pattern. From embryonic factors to the uterine environment, from laboratory conditions to maternal endocrine status, each link can be the root cause of a failed implantation. Based on clinical observations and industry consensus, this article systematically reviews the causes of failure and provides specific recommendations for subsequent evaluation and treatment directions.
===== Module A: Direct Answer =====Main Medical Causes of IVF Failure
In medical terms, IVF failure usually refers to failure to achieve clinical pregnancy after at least one embryo transfer or unsuccessful multiple transfers (recurrent implantation failure). According to data analysis from several Hong Kong fertility centers, the causes of failure can be categorized into the following four groups:
- Embryonic Factors (Highest Proportion): Chromosomal aneuploidy, poor embryo developmental potential, high fragmentation rate. This is the most common cause of single transfer failure, especially prominent in women over 38 years old.
- Uterine Factors: Decreased endometrial receptivity, intrauterine adhesions, chronic endometritis, endometrial polyps, or fibroids compressing the endometrium. Among these, chronic endometritis has a detection rate of 30–50% in patients with recurrent failure.
- Maternal Endocrine/Immune Factors: Luteal phase deficiency, thyroid dysfunction, hyperprolactinemia, antiphospholipid syndrome, or abnormal NK cell activity.
- Laboratory and Procedural Factors: Fluctuations in culture environment, embryo manipulation damage, deviation in transfer timing, or suboptimal placement of the embryo transfer catheter.
Why Embryonic Chromosomal Abnormalities Are the Primary Cause of Failure
During the meiotic division of female oocytes, the risk of chromosome non-disjunction increases significantly with age. At age 35, about 40% of eggs have chromosomal abnormalities; at age 40, this proportion rises to 60–70%, and over 43, it exceeds 80%. Abnormal embryos either fail to implant or result in early miscarriage after implantation. This is determined by biological laws, and currently, no medication or intervention can reverse the chromosomal risk associated with egg aging.
Hong Kong fertility centers generally recommend Preimplantation Genetic Testing for Aneuploidy (PGT-A) for older women (≥38 years) or patients with recurrent failure to select euploid embryos for transfer, thereby reducing the failure rate due to chromosomal abnormalities.
===== Module D: Differences by Age Group (Table) =====Failure Rate Differences and Core Causes by Age Group
| Age Group | Live Birth Rate per Transfer Cycle (Reference Range) | Primary Cause of Failure | Recommended Priority Investigation |
|---|---|---|---|
| ≤ 34 years | 40–50% | Embryonic chromosomal abnormalities (approx. 30–40%), uterine factors | Hysteroscopy, immune screening |
| 35–37 years | 30–40% | Embryonic chromosomal abnormalities (approx. 40–50%), endometrial receptivity | PGT-A, Endometrial Receptivity Analysis (ERA) |
| 38–40 years | 15–25% | Embryonic chromosomal abnormalities (60–70%), decreased egg quality | PGT-A priority, egg donation consultation |
| ≥ 41 years | 5–15% | Embryonic chromosomal abnormalities (> 80%), low oocyte yield | Embryo genetic screening, consider egg source |
* Data derived from the European Society of Human Reproduction and Embryology (ESHRE) and annual reports from several Hong Kong fertility centers; individual results vary significantly.
===== Module G: Most Easily Overlooked Details =====Most Easily Overlooked Examination Details
In retrospective analyses of failure cases, the following items are often missed or inadequately evaluated, yet they may be key factors leading to recurrent failure:
- Chronic Endometritis (CE): Difficult to diagnose with routine ultrasound and hysteroscopy; requires CD138 immunohistochemical staining. About 30–50% of patients with recurrent failure in Hong Kong have CE, and pregnancy rates can increase 2–3 times after antibiotic treatment.
- Endometrial Receptivity Analysis (ERA): Approximately 20–30% of women have a displaced window of implantation, and a standard day 5 transfer may miss the optimal implantation time.
- Thyroid Antibodies and Coagulation Function: Positive TPOAb, TGAb, as well as antiphospholipid antibodies, protein S/C deficiency, etc., have a higher detection rate in the infertile population compared to the general population.
- Male Sperm DNA Fragmentation Index (DFI): A DFI higher than 30% significantly affects embryo developmental potential, even if sperm morphology and concentration are normal.
Common Misconceptions in Clinical Decision-Making
According to practitioner observations, patients often fall into several typical decision-making pitfalls after failure, which can delay the correct treatment timing:
- Repeated transfers without etiological investigation: Choosing to transfer again after 2–3 consecutive failures without undergoing hysteroscopy, ERA, or genetic screening, leading to repeated failure.
- Over-focusing on endometrial thickness while ignoring receptivity: Endometrial thickness ≥ 7 mm is usually sufficient for implantation; the real issue is the functional state of the endometrium, not just thickness.
- Blindly adopting "immunotherapy": Using corticosteroids, immunoglobulins, or intralipids without clear evidence of immune abnormalities provides no benefit and increases risks.
- Neglecting the male factor: Attributing failure entirely to the female partner without checking sperm DNA fragmentation index or conducting genetic evaluation.
Typical Failure Case Scenario Analysis
Basic Information: 40 years old, AMH 1.2 ng/mL, 2 previous transfers with no implantation, embryo quality rated as Grade B and Grade C.
Key Examination: PGT-A results showed only 1 out of 5 blastocysts was euploid, while the other 4 had multiple chromosomal aneuploidies.
Analysis: The direct cause of failure was embryonic chromosomal abnormality. Age is the fundamental factor; even with acceptable AMH, the egg chromosomal abnormality rate exceeds 70%.
Subsequent Plan: Successful pregnancy after transferring the only euploid embryo. This case illustrates that PGT-A is strongly recommended for women ≥ 40 years old to avoid blind transfers.
Basic Information: 34 years old, Polycystic Ovary Syndrome (PCOS), first transfer of a good-quality blastocyst failed to implant, second transfer resulted in a biochemical pregnancy.
Key Examination: Hysteroscopy revealed chronic endometritis, CD138 positive; ERA indicated a 24-hour delay in the endometrial receptive phase.
Analysis: Embryo quality was normal (PGT-A confirmed euploid). The cause of failure was decreased endometrial receptivity due to endometritis, combined with a displaced implantation window.
Subsequent Plan: After 14 days of doxycycline treatment, CD138 turned negative. The transfer timing was adjusted, and the third transfer resulted in a successful pregnancy.
Basic Information: 37 years old, husband's sperm DNA fragmentation index (DFI) was 38%, 2 previous failed transfers, embryos were usable but not of high quality.
Key Examination: Male DFI was significantly elevated; chromosomal microdeletion analysis was normal; female hysteroscopy and ERA were unremarkable.
Analysis: The core cause of failure was poor embryo developmental potential due to sperm DNA damage. Even though morphological grading was acceptable, the genomic stability of the embryo was insufficient.
Subsequent Plan: Recommend lifestyle modifications for the male partner (smoking cessation, antioxidants) followed by a repeat DFI test. Consider using testicular sperm or ICSI combined with DFI selection.
Answers to Frequently Asked Questions
Q: How long should I wait after an IVF failure in Hong Kong before the next transfer?
A gap of 1–3 menstrual cycles is generally recommended, depending on the cause of failure and the body's recovery. If ovarian hyperstimulation syndrome (OHSS) or uterine procedures occurred, the interval should be extended to 2–3 months. Consecutive transfers to save time are not advised; the body and endometrium need adequate time to recover.
Q: What tests should be done after recurrent failure?
It is recommended to complete the following in order: ① Hysteroscopy + endometrial biopsy (CD138 staining); ② Endometrial Receptivity Analysis (ERA); ③ Thyroid function and antibodies, antiphospholipid antibodies, protein C/S, NK cell activity; ④ Karyotype analysis of both partners; ⑤ Sperm DNA fragmentation index. The specific tests should be tailored to the individual by a doctor.
Q: Which fertility center in Hong Kong has the lowest failure rate?
There is no center with the "lowest failure rate" because the age and cause profiles of patients vary. When choosing a center, focus on its embryology lab quality, experience with PGT technology, and ability to design individualized treatment plans, rather than simply comparing success rate numbers. It is advisable to consult the annual reports published by the Hong Kong Council on Human Reproductive Technology.
Q: Do I need PGT-A after failure?
PGT-A is recommended if any of the following conditions are met: female age ≥ 38 years; 2 or more previous failed transfers; family history of chromosomal structural abnormalities; recurrent miscarriage. For women under 35 with excellent embryo morphology scores, the benefit of PGT-A is relatively limited.
The Meaning of Failure from a Reproductive Medicine Perspective
In clinical practice, a single IVF failure is not an "outcome" but a diagnostic clue. It indicates the need for deeper investigation into aspects not covered by routine evaluations. The reproductive medicine community in Hong Kong generally believes that systematic analysis of failure cases is more valuable than simply pursuing the number of cycles. For patients with recurrent implantation failure (RIF), unlimited repeated transfers are not advocated; instead, a plan should be formulated after completing the above investigations.
Doctors often infer the cause based on the failure pattern:
- Complete failure to implant → Often related to embryonic chromosomal abnormalities or endometrial receptivity.
- Biochemical pregnancy → Suggests the embryo had developmental potential but stopped growing after implantation, possibly related to maternal immunity or the endometrial microenvironment.
- Early miscarriage → Mostly caused by embryonic chromosomal abnormalities, with maternal factors being secondary.
Management Directions for Special Situations
Very Low Ovarian Reserve (AMH < 0.5 ng/mL): These patients have a low oocyte yield per retrieval and even fewer usable euploid embryos. A cumulative cycle strategy is recommended, i.e., collecting embryos over multiple retrievals before undergoing PGT-A and transfer, rather than transferring one unscreened embryo each time.
Adenomyosis or Severe Endometrial Damage: If hysteroscopy reveals damage to the basal layer of the endometrium or adenomyosis lesions affecting endometrial blood supply, consider GnRH-a pretreatment for 2–3 months to improve the lesions before transfer, or evaluate the need for third-party assisted reproduction.
===== Risk Reminder (Ending) =====Medical evaluation after IVF failure should be conducted at a licensed fertility center. Avoid using unverified "recovery protocols" or immunosuppressants on your own. Recurrent implantation failure may involve multiple interacting factors, and single interventions are often of limited effectiveness.
Special Note: Hong Kong law requires that assisted reproductive services be performed at centers holding a valid license. Do not obtain medications or treatments through unregulated channels. All decisions involving embryo genetic testing, egg donation, or surrogacy require prior understanding of relevant regulations in Hong Kong and Mainland China to avoid legal risks.
This article is compiled based on public medical consensus in the assisted reproduction field and clinical practice in Hong Kong reproductive medicine. It is intended for informational reference only and does not constitute individual medical advice. Please consult a licensed reproductive physician for specific diagnosis and treatment plans.
0 comments